Resources

  • References


    Alexander GE, Moses H. Carbamazepine for hemifacial spasm.
    Neurology.
    1982;32:286-287.


    Defazio G, Martino D, Aniello MS, et al. Influence of age on the association between primary hemifacial spasm and arterial hypertension.
    J Neurol Neurosurg Psychiatry.
    2003;74:979-981.


    Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment.
    Adv
    Neurol.
    1988;49:151-176.


    Ehni G, Woltman HW. Hemifacial spasm.
    Arch Neurol Psychiatry.
    1945;53:205-211.


    Hemifacial spasm. EBSCO DynaMed website. Available at:
    http://www.ebscohost.com/dynamed. Accessed July 11, 2013.


    Hemifacial spasm information page. National Institute of Neurological Disorders and Stroke website. Available at:
    http://www.ninds.nih.gov/disorders/hemifacial%5Fspasm/hemifacial%5Fspasm.htm. Updated October 11, 2011. Accessed July 11, 2013.


    DynaMed's Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: 2007 safety alerts for drugs, biologics, medical devices, and dietary supplements: Carbamazepine (marketed as Carbatrol, Equetro, Tegretol and generics). Medwatch. US Food and Drug Administration website. Available at:
    http://www.fda.gov/medwatch/safety/2007/safety07.htm#carbamazepine.

  • Resources

    National Institute of Neurological Disorders and Stroke

    http://www.ninds.nih.gov

    National Organization for Rare Disorders

    http://www.rarediseases.org

  • Canadian Resources

    Canadian Movement Disorder Group

    http://www.cmdg.org

    Hemifacial Spasm Association

    http://www.hfs-assn.org